Fig. 4

Effect of REF/CLZ treatment on locomotor activity (A) and %PPI (B) against ketamine-induced schizophrenia in rats. Data are presented as mean ± SD (n = 9 and 6) using one-way ANOVA followed by Tukey as a post-hoc test (P < 0.05).